Swiss Medica Inc., Innovative Products That Improve Peoples' Lives

11/1/2004 9:11:02 AM ET

SWISS MEDICA ANNOUNCES VP OF LOGISTICS AND SUPPLY CHAIN MANAGEMENT

FOR IMMEDIATE RELEASE

Stock Symbol: OTC BB: SWME

November 1, 2004

SWISS MEDICA ANNOUNCES VP OF LOGISTICS AND SUPPLY CHAIN MANAGEMENT

Toronto, Canada – President and Chief Operating Officer Grant Johnson is delighted to announce the

appointment of Bob Esson as Swiss Medica’s Vice President of Logistics and Supply Chain Management. “Mr.

Esson brings 38 years of proven experience in manufacturing, distribution and logistics to our rapidly growing

company as we prepare for the final phase of launching the O24™ Essential Oil Pain Neutralizer into US retail

channels,” said Grant Johnson. “Mr. Esson will be based out of our contract manufacturing facility in Dallas,

Texas.”

Previously, Mr. Esson was in charge of plant management for Quaker Oats, both in the US and at overseas

locations, was the General Manager of Peachtree Windows and Doors, was the manager and distribution

consultant to Lockwood Greene and provided operational consulting services to the food & beverage industry

and pharmaceutical firms, and was senior vice president of manufacturing and distribution for BeautiControl.

Bob Esson said, “I’m very excited to join Swiss Medica and help contribute to the rapid growth and expansion of

the firm.”

About Swiss Medica Inc.

Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our

market share through focused distribution strategies in multiple sales channels. Swiss Medica’s mission is to be a

world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please

visit our websites at www.swissmedica.com and

Swiss Medica’s flagship product, the 024™ Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The

024™ pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits

by healthcare professionals in the United States, Canada and in Europe. O24 is widely available throughout

Canada in leading pharmacies and natural food stores. It is available in the United States and elsewhere by

visiting

, for ordering details and store locators.

Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United

States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking

statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close

transactions being contemplated, risks related to international sales and potential foreign currency exchange

fluctuations, continued acceptance of Swiss Medica’s products, increased levels of competition, technological

changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s

periodic reports filed with the United States Securities and Exchange Commission and other regulatory

authorities.

Investor Relations Contact:

David Jones

Swiss Medica Inc.

1 866 485 4243